Literature DB >> 35665800

Retention and Evaluation of Precision and Generic Prevention Materials for Melanoma: A Qualitative Study Comparing Young Adults and Adults.

Sylvia L Crowder1, Acadia W Buro1, John Charles A Lacson2, Youngchul Kim3, Steven K Sutton3, Richard G Roetzheim4, Susan T Vadaparampil1, Marilyn Stern5, Peter A Kanetsky2.   

Abstract

A randomized trial was conducted to examine whether providing precision prevention materials incorporating melanocortin-1 receptor genetic risk information would increase intention to practice melanoma preventive behaviors. Here, we determine retention/evaluation of prevention materials for adolescent and young adults (AYA) 18 to 39 years old versus adults aged 40+ at 6 and 12 months as an a priori adjunct analysis to the primary research question. Using qualitative methodology, open-ended questions probing most important information from prevention materials and additional comments were collected at 6 and 12 months after baseline. Descriptive statistics were performed on demographic/self-reported characteristics. Two independent researchers applied qualitative thematic content analysis to identify major themes in open-ended questions. Of the 1,134 participants randomized, 906 completed at least one of the follow-up surveys and contributed to analyses of intervention efficacy. Five major thematic categories emerged from the open-ended response data: (i) tips and tricks for sun protection; (ii) cancer prevention; (iii) risk factors and genetics; (iv) general information; and (v) intervention comments. Across all ages, the most important information retained were sun protection techniques in the generic prevention materials group and identifying the importance of genetic risk factors/implementing lifestyle behavior changes in the precision prevention materials group. For additional comments, AYA participants in the generic prevention materials group preferred more scientific information including statistics and citations for references while adults were more likely to state they already knew cancer prevention techniques. Results provide unique qualitative evaluation of AYA versus adult retention of prevention materials for melanoma that enhance quantitative findings. PREVENTION RELEVANCE: It is important to evaluate information within groups defined by periods of the life trajectory, e.g., AYA and adults, to best inform preferences, knowledge, and motivation for behavior change. By assessing retention, evidence-based interventions can be designed to better support public health messaging and encourage positive health behaviors. ©2022 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2022        PMID: 35665800      PMCID: PMC9357111          DOI: 10.1158/1940-6207.CAPR-22-0033

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  33 in total

1.  Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?

Authors:  Peter A Kanetsky; Saarene Panossian; David E Elder; DuPont Guerry; Michael E Ming; Lynn Schuchter; Timothy R Rebbeck
Journal:  Cancer       Date:  2010-05-15       Impact factor: 6.860

2.  Exploring the emotional and behavioural reactions to receiving personalized melanoma genomic risk information: a qualitative study.

Authors:  G L Fenton; A K Smit; L Keogh; A E Cust
Journal:  Br J Dermatol       Date:  2019-03-04       Impact factor: 9.302

3.  A randomized clinical trial of precision prevention materials incorporating MC1R genetic risk to improve skin cancer prevention activities among Hispanics.

Authors:  John Charles A Lacson; Scarlet H Doyle; Jocelyn Del Rio; Stephanie M Forgas; Rodrigo Carvajal; Guillermo Gonzalez-Calderon; Adriana Ramírez Feliciano; Youngchul Kim; Richard G Roetzheim; Steven K Sutton; Susan T Vadaparampil; Brenda Soto-Torres; Peter A Kanetsky
Journal:  Cancer Res Commun       Date:  2022-01-11

Review 4.  A systematic review of interventions to improve adherence to melanoma preventive behaviors for individuals at elevated risk.

Authors:  Yelena P Wu; Lisa G Aspinwall; Bridgid M Conn; Tammy Stump; Bridget Grahmann; Sancy A Leachman
Journal:  Prev Med       Date:  2016-04-16       Impact factor: 4.018

5.  Attitudes about genetic testing for breast-ovarian cancer susceptibility.

Authors:  C Lerman; M Daly; A Masny; A Balshem
Journal:  J Clin Oncol       Date:  1994-04       Impact factor: 44.544

Review 6.  Survivorship considerations in adults with hereditary breast and ovarian cancer syndrome: state of the science.

Authors:  Cheryl B Crotser; Marcia Boehmke
Journal:  J Cancer Surviv       Date:  2009-01-23       Impact factor: 4.442

7.  Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response.

Authors:  Monique K van der Kooij; Marjolein J A L Wetzels; Maureen J B Aarts; Franchette W P J van den Berkmortel; Christian U Blank; Marye J Boers-Sonderen; Miranda P Dierselhuis; Jan Willem B de Groot; Geke A P Hospers; Djura Piersma; Rozemarijn S van Rijn; Karijn P M Suijkerbuijk; Albert J Ten Tije; Astrid A M van der Veldt; Gerard Vreugdenhil; Michel W J M Wouters; John B A G Haanen; Alfonsus J M van den Eertwegh; Esther Bastiaannet; Ellen Kapiteijn
Journal:  Cancers (Basel)       Date:  2020-07-27       Impact factor: 6.639

8.  A Randomized Trial of Precision Prevention Materials to Improve Primary and Secondary Melanoma Prevention Activities among Individuals with Limited Melanoma Risk Phenotypes.

Authors:  John Charles A Lacson; Scarlet H Doyle; Lu Qian; Jocelyn Del Rio; Stephanie M Forgas; Stella Valavanis; Rodrigo Carvajal; Guillermo Gonzalez-Calderon; Youngchul Kim; Richard G Roetzheim; Steven K Sutton; Susan T Vadaparampil; Peter A Kanetsky
Journal:  Cancers (Basel)       Date:  2021-06-23       Impact factor: 6.639

9.  MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project.

Authors:  Elena Pasquali; José C García-Borrón; Maria Concetta Fargnoli; Sara Gandini; Patrick Maisonneuve; Vincenzo Bagnardi; Claudia Specchia; Fan Liu; Manfred Kayser; Tamar Nijsten; Eduardo Nagore; Rajiv Kumar; Johan Hansson; Peter A Kanetsky; Paola Ghiorzo; Tadeusz Debniak; Wojciech Branicki; Nelleke A Gruis; Jiali Han; Terry Dwyer; Leigh Blizzard; Maria Teresa Landi; Giuseppe Palmieri; Gloria Ribas; Alexander Stratigos; M Laurin Council; Philippe Autier; Julian Little; Julia Newton-Bishop; Francesco Sera; Sara Raimondi
Journal:  Int J Cancer       Date:  2014-06-18       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.